In one of several cases over the past years surrounding the Internal Revenue Service’s ability to investigate and impose tax consequences on marijuana-related business...
Fox Rothschild announced May 11 that Christopher Groen was elevated to partner in the firm’s Denver office.
Groen practices in commercial litigation and represents companies...
Marijuana is still a Schedule I drug, but federal lawmakers are increasingly paying attention to the challenges the illegal classification creates for marijuana businesses...
